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Herpes simplex virus 1 (HSV-1) ICP27 and ICP8 proteins have both been implicated in the transcription of late genes and regulation of
viral gene expression. We showed previously that ICP27 and ICP8 associate with the RNAP II holoenzyme (Zhou and Knipe, J. Virol. 76,
5893–5904). Here, we demonstrate that ICP27 and ICP8 coprecipitate from lysates of HSV-1-infected HEp2 cells and from lysates of insect
cells expressing ICP27 and ICP8, the latter being in the absence of other HSV-1 proteins. By expressing and purifying hexahistidine-tagged
ICP8 (His-ICP8) and maltose binding protein (MBP)-tagged ICP27 (MBP-27) proteins and performing in vitro immunoprecipitation and
pull-down assays, we also demonstrate that ICP27 and ICP8 coprecipitate in the absence of other viral or cellular proteins. Taken together,
these data provide evidence that ICP27 and ICP8 interact directly in vitro and in infected cells. We hypothesize that the ICP27–ICP8
interaction plays a role in the stimulation of late gene transcription.
D 2004 Elsevier Inc. All rights reserved.
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The human herpes simplex virus 1 (HSV-1) has a linear,
double-stranded DNA genome, encoding at least 80 genes
that are transcribed in the cell nucleus by the host RNA
polymerase II (RNAP II). The viral genes are expressed in a
well-regulated, temporal fashion and can be divided into
three broad classes: a or immediate-early (IE) genes, h or
early (E) genes, and g or late (L) genes (reviewed in
Roizman and Knipe, 2001). The L gene class can be further
subdivided into g1 and g2 genes, the latter of which
absolutely requires viral DNA replication for expression.
Transcription of the five IE genes (ICP4, ICP0, ICP27,
ICP22, and ICP47) is stimulated by the VP16 virion protein
and does not require prior viral protein synthesis. Expres-
sion of the E proteins, which predominately include proteins
essential for viral DNA synthesis, is regulated by IE
proteins. Following the synthesis of E proteins and viral0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: david_knipe@hms.harvard.edu (D.M. Knipe).DNA replication, the L gene products are expressed, which
consist mainly of viral structural proteins involved in virion
assembly and maturation.
The expression of E and L proteins is dependent upon
functional ICP4 and ICP27. ICP4 is a site-specific DNA-
binding protein (Beard et al., 1986; Faber and Wilcox, 1986,
1988; Kristie and Roizman, 1986a, 1986b; Michael et al.,
1988; Purifoy and Powell, 1976) that interacts with basal
transcription factors, including TFIID, TFIIB, TATA-bind-
ing protein (TBP), and TAF250 (Carrozza and DeLuca,
1996, 1998; Grondin and DeLuca, 2000; Smith et al., 1993),
to activate the transcription of most early and late genes and
repress the transcription of certain IE genes (DeLuca and
Schaffer, 1985; DeLuca et al., 1985; Godowski and Knipe,
1986; Kuddus et al., 1995; O’Hare and Hayward, 1985;
Preston, 1979). ICP27 is a nuclear IE phosphoprotein
(Ackermann et al., 1984; Wilcox et al., 1980; Zhi and
Sandri-Goldin, 1999) that is required for productive HSV-1
infection and is an essential regulator of viral gene
expression (McCarthy et al., 1989; Rice and Knipe, 1990;
Rice et al., 1989; Sacks et al., 1985).
Studies with ICP27 gene null and deletion mutants have
demonstrated that ICP27 stimulates the synthesis of several05) 94–105
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expression of certain IE and E proteins and induces the
expression of g1 and g2 gene mRNAs and proteins, thereby
promoting the switch from early to late gene expression.
ICP27 also significantly enhances HSV-1 DNA synthesis,
most likely by inducing the expression of E proteins
essential for viral DNA replication (Uprichard and Knipe,
1996). The effects of ICP27 on viral DNA replication and
g2 gene expression are distinct. This is demonstrated by an
ICP27 mutant (n504) virus that replicates viral DNA and
expresses g1 proteins to near wild-type (wt) levels, but does
not express g2 proteins (Jean et al., 2001; Rice and Knipe,
1990). Studies with n504 virus-infected cells further show
that ICP27 stimulates the transcription of at least two late
genes, gC and UL47 (Jean et al., 2001). In support of a role
for ICP27 as a transcriptional regulator, ICP27 has been
shown to accumulate in replication compartments (de Bruyn
Kops et al., 1998), interact with the cellular RNAP II
(Jenkins and Spencer, 2001; Zhou and Knipe, 2002) and
with viral ICP0 and ICP4 proteins (Mullen et al., 1995;
Panagiotidis et al., 1997), and affect the posttranslational
modification and DNA-binding activity of ICP4 (Sama-
niego et al., 1995; Xia et al., 1996).
Other studies have also concluded that ICP27 functions
at the posttranscriptional level. ICP27 binds to RNA in vitro
and to many HSV-1 transcripts of all kinetic classes in vivo,
primarily via the N-terminal RGG box RNA binding motif
(Ingram et al., 1996; Mears and Rice, 1996; Sandri-Goldin,
1998; Sokolowski et al., 2003). In infected or transfected
cells, ICP27 regulates 3Vprocessing of pre-mRNAs (Ellison
et al., 2000; Hann et al., 1998; McGregor et al., 1996;
McLauchlan et al., 1992), stabilizes labile 3Vends of mRNAs
(Brown et al., 1995), and contributes to host shut-off (Song
et al., 2001) through inhibition of host cellular pre-mRNA
splicing (Hardwicke and Sandri-Goldin, 1994a, 1994b;
Lindberg and Kreivi, 2002) and retention of some intron-
containing transcripts in the nucleus (Phelan et al., 1996). In
agreement with its posttranscriptional functions, ICP27 was
reported to interact with a variety of cellular proteins,
including p32 (Bryant et al., 2000), SAP145 (Bryant et al.,
2001), SRPK1 (Sciabica et al., 2003), Aly/REF (Chen et al.,
2002), hnRNP K, and CK2 (Wadd et al., 1999). Later in
infection, low levels of ICP27 shuttle between the cell
nucleus and the cytoplasm, and ICP27 has been reported to
promote the nuclear export of late viral mRNAs (reviewed
in Sandri-Goldin, 2004); however, recent data have shown
that the ICP27-mediated cytoplasmic accumulation of
mRNAs is restricted to a limited number of transcripts
(Pearson et al., 2004).
ICP8 is one of seven early viral proteins essential for viral
genome replication (Challberg, 1986; Conley et al., 1981);
reviewed in Lehman and Boehmer, 1999) that binds tightly
and cooperatively to ssDNA (Lee and Knipe, 1985; Ruye-
chan, 1983, 1988), destabilizes dsDNA helices (Boehmer and
Lehman, 1993), promotes DNA strand transfer (Bortner et al.,
1993), and promotes renaturation of ssDNA (Dutch andLehman, 1993). ICP8 also regulates viral gene expression by
repressing transcription from the parental viral genome
(Godowski and Knipe, 1983, 1985, 1986) and stimulating L
gene expression from the progeny genome (Gao and Knipe,
1991). ICP8 has recently been shown to associate in
replication compartments with over 50 cellular and viral
proteins—many of which are involved in DNA replication
and repair, recombination, and chromatin modeling (Taylor
and Knipe, 2004). ICP8 also associates with ICP4, ICP27,
and cellular RNAP II; however, the association of ICP8 with
RNAP II is dependent on the expression of a functional ICP27
(Zhou and Knipe, 2002).
Given that ICP27 is required for ICP8 to associate with
RNAP II and that ICP27 and ICP8 are essential positive
regulators of late gene expression, we hypothesized a direct
interaction between ICP27 and ICP8. In the present study,
we show that ICP27 and ICP8 specifically associate in
HSV-1-infected cells. In addition, ICP27 and ICP8 associate
in insect cells in the absence of other viral proteins. Finally,
we provide evidence using purified, tagged proteins that
ICP27 and ICP8 interact directly. We propose that the
ICP27–ICP8 interaction plays a crucial role in stimulating
the transcription of viral L genes.Results
ICP27 and ICP8 specifically associate in HSV-1-infected
cells
Previous studies from our lab have suggested an
interaction between HSV-1 ICP27 and ICP8. We have
shown that ICP27 and ICP8 associate with the cellular
RNAP II holoenzyme in HSV-1-infected HEp-2 cells (Zhou
and Knipe, 2002). In addition, the association of ICP8 with
RNAP II required functional ICP27. We also observed that
ICP8 co-immunoprecipitated with ICP27 using anti-ICP27
H1119 mAb (Zhou and Knipe, 2002) and ICP27 co-
immunoprecipitated with ICP8 using anti-ICP8 39S mAb
(Taylor and Knipe, 2004), suggesting an interaction between
ICP27 and ICP8. In this study, we sought to further
investigate a potential interaction between the two proteins.
In the first set of experiments, we tested the association
between ICP27 and ICP8 in HSV-1-infected cells. HEp-2
cells were mock infected or infected with wt virus or d27-1
virus, an ICP27 null deletion mutant. Cells were harvested at
8 hpi, and immunoprecipitations were performed on the
cellular lysates with antibodies either to ICP27 (H1119 mAb)
or ICP8 (3-83 pAb). In ICP27 immunoprecipitations, ICP8
co-immunoprecipitated from wt virus-infected cellular
lysates (Fig. 1A, lane 6). Conversely, ICP27 co-immuno-
precipitated with ICP8 from wt virus-infected cellular lysates
(Fig. 1B, lane 6). Little to no ICP27 or ICP8 precipitated with
the beads alone, that is, without primary antibody (Fig. 1B,
lane 7). Furthermore, ICP8 did not precipitate with H1119
mAb in the absence of ICP27, that is, from cell lysates
Fig. 1. Co-precipitation of ICP27 and ICP8 from HSV-1-infected cells. HEp-2 cells were infected with wt or ICP27 deletion mutant (d27-1) viruses or mock
infected, and the cells were harvested at 8 hpi. Immunoprecipitations (IP) were performed on cell lysates with (A) a-ICP27 H1119 mAb, (B) a-ICP8 3-83 pAb,
or no antibody (beads). Proteins in the lysate (1% of the total precleared lysate used in immunoprecipitations was loaded on the gel) and in the IP were resolved
by SDS-PAGE and detected by Western blotting (WB) with H1119 (1:300 dilution) or 3-83 (1:1000 dilution) as primary antibodies. MW; molecular weight of
the protein standards.
Table 1
ICP27 gene expression constructs complement the viral growth defect of
the HSV-1 d27-1 deletion mutant virus
Transfected plasmida Yield (PFU/ml)b Complementation
indexc
pCIDAflII vector 3.2  103; 3.8  103 –
pCI-(MBP-ICP27) 3.0  105; 4.4  105 100
pCI-ICP27 1.3  107; 1.3  107 3700
pPs27pd1 3.4  107; 4.2  107 10,000
a Vero cells were transfected with 1.5 Ag of pCI-ICP27, pCI-MBP-ICP27,
pCI alone (mock; negative control), or pPs27pd1 (positive control)
plasmids. Cells were infected with d27-1 virus and harvested at 24 hpi.
b Virus yields were determined in duplicate on V827 cells.
c Fold complementation of d27-1 virus by transfected plasmid above
mock-transfected.
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that the co-immunoprecipitation of ICP27 and ICP8 was
specific. Previous immunoprecipitation studies from infected
cell lysates used a monoclonal antibody to ICP8 (39S)
(Taylor and Knipe, 2004). Here, we used an antibody other
than 39S that also recognizes ICP8 (3-83) to further
demonstrate an association between ICP27 and ICP8.
Therefore, these results showed a specific association
between ICP27 and ICP8 during HSV-1 infection.
Characterization of ICP27 and His-tagged ICP8 proteins
We next determined if other HSV-1 proteins were
necessary for the association between ICP27 and ICP8. To
address this, we tested if ICP27 and His-tagged ICP8 (His-
ICP8) expressed by recombinant baculoviruses in insect
cells could co-immunoprecipitate in the absence of other
HSV-1 proteins. Before beginning the immunoprecipitation
experiments, it was necessary to ensure that the ICP27 and
ICP8 constructs we used produced stable, functional
proteins. We first tested the ICP27 gene construct with a
complementation assay performed in mammalian cells. The
ICP27 open reading frame (ORF) was inserted into the
pCIDAflII mammalian expression vector and tested for its
ability to complement the ICP27 null deletion virus d27-1.
The pCI-ICP27 plasmid complemented the growth of the
d27-1 virus to a titer 104-fold higher than that in cells
transfected with the pCIDAflII vector (Table 1). In addition,
this level of complementation was similar to that of the
positive control pPs27pd1, which expressed full-length
ICP27 under the control of the endogenous viral promoter.
Thus, the subcloned ICP27 gene translated into a functional
protein in mammalian cells. Because insect cells are func-
tionally similar to mammalian cells in that both cell types
incorporate posttranslational modifications, splice genes,
and compartmentalize proteins (King and Possee, 1992;Luckow, 1991), these data suggested the insect baculovirus
vector would express a functional ICP27 protein.
Several investigators have generated and expressed His-
tagged ICP8 that is similar to our recombinant protein to high
levels in insect cells. These investigators have provided
evidence that ICP8 expressed by baculovirus recombinant
binds cooperatively to short DNA poly (dT) oligonucleotides
and to ssDNA agarose (Dudas and Ruyechan, 1998; Mapelli
et al., 2000; Spatz et al., 1999). In addition, these properties of
ICP8 are not disrupted by the presence of a hexahistidine tag
(Spatz et al., 1999). Nevertheless, we tested whether our His-
ICP8-retained ssDNA-binding activity to the same levels
reported for wt ICP8. Cellular lysate from SF21 cells infected
with the recombinant ICP8 baculovirus was passed over an
ssDNA agarose column and His-ICP8 was eluted with buffer
containing increasing amounts of salt. His-ICP8 had an
elution profile similar to wt ICP8 (data not shown; Gao and
Knipe, 1989; Lee and Knipe, 1985), suggesting that the
protein was functional and had similar DNA binding
properties compared with wt. Therefore, we concluded that
Fig. 3. SDS-PAGE analysis of recombinant MBP-27 and His-ICP8 protein
expression and purification. Purified proteins were subjected to SDS-PAGE
and stained with Coomassie Brilliant Blue R-250. (A) MBP-27 was
expressed in E. coli and purified on amylose resin. The line (-) indicates
full-length MBP-27. The dots (.) indicate degradation or truncation
products of MBP-27. (B) His-ICP8 was expressed in Hi5Tn insect cells
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ruses were functional.
ICP27 and His-ICP8 co-immunoprecipitated in the absence
of other HSV-1 proteins
To address whether ICP27 and ICP8 associate without
other HSV-1 proteins, SF21 insect cells were mock infected,
infected with baculoviruses expressing ICP27 or His-ICP8,
or co-infected with ICP27 and His-ICP8 baculoviruses.
Cells were harvested at 72 hpi, and immunoprecipitations
were performed on cellular lysates with either anti-ICP27
H1119 mAb or anti-ICP8 3-83 pAb. The co-immunopreci-
pitated proteins were separated by SDS-PAGE and detected
by Western blot analysis with either H1119 or 3-83 as
primary antibodies.
His-ICP8 co-immunoprecipitated with ICP27 from cellu-
lar lysates expressing both ICP27 and His-ICP8 recombinant
proteins in immunoprecipitations performed with H1119
(Fig. 2A, lane 8). In contrast, His-ICP8 did not precipitate
with H1119 from cellular lysates infected only with the His-
ICP8 baculovirus (Fig. 2A, lane 7). Similarly, the reverse
experiment showed that ICP27 co-immunoprecipitated with
His-ICP8 in experiments performed with 3-83 pAb (Fig. 2B,Fig. 2. Co-precipitation of ICP27 and ICP8 in the absence of additional HSV-
1 proteins. ICP27 and His-ICP8 proteins were expressed individually or co-
expressed by recombinant baculoviruses in SF21 insect cells and harvested at
72 hpi. (A) Immunoprecipitations (IP) were performed on cell lysates with
the a-ICP27 H1119 mAb. Proteins in the cellular lysates (1% of the total
precleared lysate used in the IP was loaded on the gel) and in the IP were
resolved via SDS-PAGE and detected by Western blotting (WB) with H1119
mAb (1:300 dilution) or a-ICP8 3-83 pAb (1:1000 dilution) as primary
antibodies. (B) Immunoprecipitations were performed on cellular lysates
with 3-83 pAb and proteins were detected with H1119 or 3-83 antibodies.
that were infected with the recombinant ICP8 baculovirus and was purified
via a three-step purification protocol (see Materials and methods). The line
(-) indicates His-ICP8. MW; molecular weight of the protein standards.lane 8), but not in the absence of His-ICP8 (Fig. 2B, lane 6).
The failure of ICP8 to precipitate with the anti-ICP27
antibody without the expression of ICP27, and vice versa,
indicated that ICP27 and ICP8 specifically associated when
expressed in insect cells and that other HSV proteins were not
necessary for the ICP27–ICP8 association.
Characterization and co-precipitation of tagged ICP27
(MBP-27) and ICP8 (His-ICP8)
We further determined if purified ICP27 and ICP8
proteins could interact directly in vitro. To determine this,
we expressed affinity-tagged ICP27 and ICP8 constructs to
ease purification. For these experiments, we made use of
His-ICP8 expressed by the recombinant ICP8 baculovirus
described above, which we expressed to high levels in
TnHi5 insect cells and purified to near homogeneity via a
three-column protocol (Fig. 3B, lane 4).
Unfortunately, many investigators have had little success
expressing full-length ICP27 with an N-terminal affinity tag
to high levels (Mears and Rice, 1996; Sciabica et al., 2003;
Jean and Knipe, unpublished data). We made several
unsuccessful attempts to express ICP27 with N-terminal
hexahistidine or GST affinity tags in insect cells. His-tagged
ICP27 was expressed to negligible levels in insect cells, and
the GST-tagged ICP27 protein was insoluble (results not
shown). Because expression as a maltose binding protein
(MBP) fusion protein has increased the solubility of several
proteins expressed in bacteria (Planson et al., 2003), we
Fig. 4. Co-precipitation of MBP-27 with His-ICP8 in vitro. MBP-27 and
His-ICP8 were expressed and purified as described in Materials and
methods. One microgram each of MBP-27 and His-ICP8 were incubated
separately or together overnight in IP buffer. (A) Immunoprecipitations
were performed with a-ICP8 3-83 pAb. Input protein (10 ng) and
immunoprecipitates were resolved by SDS-PAGE, and MBP-27 was
detected by Western blotting with a-MBP mAb (1:10,000 dilution) as the
primary antibody. (B) The membrane was stripped and reprobed with 3-83
pAb (1:1000) by Western blotting to detect ICP8. IP; immunoprecipitation.
WB; Western blot. MW; molecular weight of the protein standards.
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fused to the C-terminus of Escherichia coli MBP. MBP-27
was expressed in E. coli and partially purified on amylose
resin, which binds with high affinity and specificity to E. coli
MBP. Similar to other reports for ICP27 proteins expressed in
bacteria, we observed prominent bands that were likely to be
degraded or truncated MBP-27 products, but were able to
obtain soluble full-lengthMBP-27 (Fig. 3A, lane 2). Previous
reports have shown that H1119 mAb does not recognize N-
terminally tagged ICP27 proteins, likely because the tag
masks the antibody recognition site. H1119 did not detect
MBP-27 in Western blots, but we confirmed the identity of
MBP-27 byWestern blottingwith an antibody toMBP and by
mass spectrometry (results not shown).
To test the functionality of the MBP-27 protein, we cloned
the ORF encoding MBP-27 into the pCIDAflII expression
vector (pCI-MBP27) and performed a complementation
assay to determine if pCI-MBP27 could complement the
growth of the ICP27 null deletion virus d27-1 in mammalian
cells. The pCI-MBP27 plasmid complemented d27-1 viral
growth by 100-fold greater than mock (pCIDAflII)-trans-
fected cells, but 40-fold less than wt pCI-ICP27 (Table 1).
Thus, the gene encodingMBP-27 translated into a protein that
retained most wt functions. We are not certain why MBP-27
did not complement d27-1 as well as wt ICP27, but possible
explanations include interference by the MBP tag, differing
levels of ICP27 and MBP-27 protein expression, or altered
structure of MBP-27 compared with wt ICP27 in Vero cells.
To determine if MBP-27 could co-immunoprecipitate
with His-ICP8 in vitro, these tagged proteins were expressed
and purified as described in Materials and methods and were
incubated separately or together in IP buffer overnight.
Immunoprecipitations were then performed on these sam-
ples with the anti-ICP8 3-83 pAb. MBP-27 co-immunopre-
cipitated with His-ICP8 (Fig. 4A, lane 4). We occasionally
observed a low level of background when MBP-27 was
incubated with 3-83 pAb alone (Fig. 4A, lane 2); however,
the Western blot signal for MBP-27 when both proteins
were incubated together was consistently higher, demon-
strating specificity for the interaction. In addition, neither
MBP-27 nor His-ICP8 was precipitated when incubated
together with a bead control in the absence of antibody (data
not shown). Interestingly, even though our partially purified
MBP-27 preparation contained two highly expressed MBP-
27 degradation or truncation products (Fig. 3, lane 2; and
Fig. 4A, lane 1), these products did not co-precipitate with
ICP8 (Fig. 4A, lane 4). The blot was subsequently stripped
and probed with 3-83 pAb by Western blotting to detect His-
ICP8 in the immunoprecipitated samples (Fig. 4B, lanes 1
and 3–4). The results of these experiments provide evidence
for a direct interaction between ICP27 and ICP8.
The reverse immunoprecipitations were not feasible
because available antibodies did not recognize MBP-27 in
immunoprecipitation assays. Therefore, we used protein
affinity pull-down assays as an alternative approach to
determine whether ICP27 and ICP8 interact directly. MBPor the MBP-27 fusion was expressed in E. coli and bound
to amylose resin. The conjugated beads were washed
extensively to remove the loosely bound E. coli proteins
and incubated with purified His-ICP8. The beads were
washed and boiled in protein loading buffer, and bound
proteins were detected by SDS-PAGE and Western blot.
His-ICP8 bound to MBP-27 (Fig. 5A, lane 4), but not to
MBP or to resin alone (Fig. 5A, lanes 3 and 2,
respectively). Moreover, reovirus A2 protein that was
expressed in and purified from insect cells did not bind
MBP-27 or MBP in pull-down experiments (Fontaine-
Rodriguez et al., in press). These negative controls
demonstrate additional specificity for the interaction of
His-ICP8 with MBP-27. The blot was stripped and probed
with an antibody against MBP to show that MBP and
MBP-27 were bound to amylose resin (Fig. 5B). These
results provide evidence for a direct interaction between
ICP27 and ICP8.
Previous studies, which showed that ICP27 and ICP8
associated in HSV-1-infected HEp-2 cells in the presence of
RNase or ethidium bromide (EtBr), suggested that RNA or
DNA did not mediate the ICP27–ICP8 association (Taylor
and Knipe, 2004; Zhou and Knipe, 2002). The conditions of
our purification schemes for His-ICP8, which included the
presence of DNase and levels of salt high enough to disrupt
protein–nucleic acid interactions, as well as the ability of
His-ICP8 to bind an ssDNA column suggested that neither
DNA nor RNA was present in the purified preparation we
used for in vitro assays. However, we considered that nucleic
acids could be present in our partially purified MBP-27
preparations. Therefore, to confirm that the interaction
Fig. 5. Co-precipitation of His-ICP8 with MBP-27 in vitro. (A) Purified
His-ICP8 (2.5 Ag) was incubated with amylose resin or with MBP or MBP-
27 fusion bound to amylose resin as described in Materials and methods.
The beads were washed with MBP buffer and heated at 80 8C in sample
buffer for 10 min prior to analysis via SDS-PAGE and Western blot. His-
ICP8 was detected with a-ICP8 3-83 pAb (1:1000) by Western blotting.
One percent of the total protein used in the pull-down was loaded in the
input lane. (B) The membrane was stripped and reprobed with a-MBP mAb
(1:10,000) by Western blotting. WB: Western blot. MW; molecular weight
of the protein standards.
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down assay in which bacterial lysates containing MBP and
MBP-27 were treated with RNase and DNase prior to
binding to amylose resin. His-ICP8 co-precipitated with
MBP-27 with or without nuclease treatment (Fig. 6, lanes 4
and 5), but did not co-precipitate with MBP in either
condition (Fig. 6, lanes 2 and 3). Taken together, these results
and those of the aforementioned studies with virus-infected
cells (Taylor and Knipe, 2004; Zhou and Knipe, 2002) argue
strongly that the ICP27–ICP8 interaction is direct and
mediated primarily by protein–protein interactions.Fig. 6. Role of nucleic acids in the interaction of His-ICP8 with MBP-27.
Cleared bacterial lysates containing MBP or the MBP-27 fusion were
treated with RNAse and DNAse for 30 min. Purified His-ICP8 (2.5 Ag) was
then incubated with MBP or MBP-27 fusion bound to amylose resin as
described in Materials and methods. The beads were washed with MBP
buffer and heated at 80 8C in sample buffer for 10 min prior to analysis via
SDS-PAGE and Western blot. His-ICP8 was detected with a-ICP8 3-83
pAb (1:1000) by Western blotting. One percent of the total protein used in
the pull-down was loaded in the input lane. WB: Western blot.Discussion
ICP27 and ICP8 interact directly
Previous studies from our laboratory suggested a direct
interaction between ICP27 and ICP8. Both ICP27 and ICP8
associated with RNAP II in lysates of HSV-1-infected cells
(Jenkins and Spencer, 2001; Zhou and Knipe, 2002).Furthermore, the association of ICP8 with RNAP II required
the presence of a functional ICP27 (Zhou and Knipe, 2002).
ICP27 was also shown to co-precipitate with ICP8 from
replication compartments of HSV-1-infected cells (Taylor
and Knipe, 2004). In this study, we have extended past work
and present novel evidence that ICP27 and ICP8 interact
directly and specifically, and in the absence of other HSV-1
or cellular proteins.
Previous studies have shown that the association of
ICP27 and ICP8 in HSV-1-infected HEp-2 cells is not
disrupted in the presence of RNAse or ethidium bromide
(EtBr), suggesting that RNA or DNA did not mediate their
association (Taylor and Knipe, 2004; Zhou and Knipe,
2002). To exclude the possibility that RNA or DNA was
mediating the ICP27–ICP8 interaction, we performed pull-
down assays in the presence of RNase and DNase and
observed a direct interaction of purified His-tagged ICP8
with MBP-27. We therefore concluded that the interaction
between ICP27 and ICP8 was mediated predominantly by
protein–protein interactions.
Although we have shown evidence for a bona fide ICP27–
ICP8 interaction, we cannot exclude the possibility that the
interaction could be strengthened via associations with other
viral or cellular proteins during HSV-1 infection. Support for
assistance from other proteins extends from the ability of
ICP27 to interact with RNAP II and ICP4 (see below).
ICP27 and ICP8 mutants share defects in late gene
expression
Studies with the n504 ICP27 and d105 ICP8 mutants
support the idea of a direct ICP27–ICP8 interaction. The
n504 ICP27 nonsense mutant virus, which encodes the N-
terminal 504 amino acid residues of ICP27, is defective for
L gene (g2) expression, but replicates near wt levels of
DNA (Jean et al., 2001; Rice and Knipe, 1990). The d105
ICP8 mutant is a dominant-negative form of ICP8 that lacks
residues 1083–1166 (Chen and Knipe, 1996; Gao and
Knipe, 1991). Cells expressing d105 ICP8 and infected with
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levels of g1 (ICP5, ICP25) and g2 (ICP15, gC, UL47)
genes compared with wt virus-infected cells. Furthermore,
the effects on L gene transcription were independent of viral
DNA synthesis (Chen and Knipe, 1996). Given that
mutations in these two genes impart similar functional
consequences, these data suggest that ICP27 and ICP8
collaborate in the mechanism by which L genes are
expressed. Moreover, these data are consistent with a direct
interaction between ICP27 and ICP8 during viral infection.
Because results with the n504 ICP27 virus show that amino
acid residues in the C-terminus of ICP27 are necessary for at
least the expression of g2 late genes, we are currently
exploring the requirement of specific amino acid residues
within the C-terminus for the ICP27–ICP8 interaction.
Implications of the ICP27 and ICP8 interaction in viral
gene expression
Both ICP27 and ICP8 have been implicated in the
stimulation of transcription of several true L genes. The
mechanism by which ICP27 and ICP8 stimulate L gene
transcription has not been defined previously, but ICP27
was shown to associate and co-localize with RNAP II, ICP8,
and ICP4 in replication compartments (de Bruyn Kops et al.,
1998; Taylor and Knipe, 2004; Zhou and Knipe, 2002),
which are sites where viral DNA replication and viral gene
transcription are thought to occur. Moreover, ICP27 showed
a direct interaction with ICP4 (Mullen et al., 1995;
Panagiotidis et al., 1997), which is a site-specific DNA
binding protein (Beard et al., 1986; Faber and Wilcox, 1986,
1988; Kristie and Roizman, 1986a, 1986b; Michael et al.,
1988; Purifoy and Powell, 1976) that associates with
general transcription factors (Carrozza and DeLuca, 1996,
1998; Grondin and DeLuca, 2000; Smith et al., 1993)
presumably to promote transcription of viral mRNA. We
show here that ICP27 also interacts with ICP8, an ssDNA
binding protein that stimulates L gene expression, like
ICP27, specifically from the progeny viral genome (Gao and
Knipe, 1991). We therefore propose that the interaction of
ICP27 and ICP8, and their associations with other viral and
cellular proteins (i.e., RNAP II and ICP4), play a role in
stimulating transcription of at least viral L genes. Our
heuristic model predicts that ICP27 binds to RNAP II (Zhou
and Knipe, 2002), and this complex is recruited to viral
DNA via interactions of ICP27 with ICP8 and ICP4 (Fig. 7).
These interactions may serve to bring RNAP II to progeny
viral DNA, thereby promoting the efficient transcription of
viral L genes.
Our data provide evidence for a genuine and potentially
functionally relevant ICP27–ICP8 interaction. The interac-
tion between ICP27 and ICP8 may serve to stimulate at least
the expression, if not transcription, of certain viral genes.
Currently, we are investigating the regions of ICP27
responsible for interactions with ICP8 and vice versa.
Efforts to determine the three-dimensional structure ofICP8 (Mapelli and Tucker, 1999), ICP27, and the complex
of the two proteins should help to further elucidate the
mechanisms by which HSV-1 commandeers the host cell
nucleus.Materials and methods
Materials
The H1119 ICP27-specific mouse monoclonal antibody
(mAb) (Ackermann et al., 1984) was purchased from the
Goodwin Institute for Cancer Research Inc. (Plantation,
FL). The 3-83 ICP8-specific rabbit polyclonal antibody
(pAb) was described previously (Knipe et al., 1987). Anti-
MBP mAb was purchased from New England Biolabs
(Beverly, MA).
Cell culture
African green monkey kidney (Vero), human 293, and
human epidermoid (HEp2) cells were obtained from the
American Type Culture Collection (Manassas, VA) and
maintained in Dulbecco’s modified Eagle’s medium (Media
Tech Inc., Herndon, VA) supplemented with 5% fetal
bovine serum (FBS) (Invitrogen, Carlsbad, CA) plus 5%
fetal calf serum (FCS) (Hyclone, Logan, UT), streptomycin
(100 Ag/ml), and penicillin (100 U/ml) (DMEM + 10%
FBCS). V827 cells (Da Costa et al., 2000), which contain
an integrated copy of the ICP27 and ICP8 genes, were also
grown in DMEM + 10% FBCS. SF21 cells were grown in
Grace’s insect media plus 10% FBS and streptomycin
(100 Ag/ml) and penicillin (100 U/ml) at 27 8C (Invitrogen).
TnHi5 cells were maintained in spinner cultures in Express
Five SFM supplemented with 18 mM l-glutamine, and
streptomycin (100 Ag/ml) and penicillin (100 U/ml) at 27
8C (Invitrogen).
Plasmids, baculoviruses, and HSV-1 strains
The pPs27pd1 plasmid was described previously (Rice et
al., 1989). To construct the pCI-ICP27 plasmid, which
expresses ICP27 in mammalian cells, the ICP27 open
reading frame (ORF) was first amplified from pPs27pd1
with the Advantage GC-2 PCR kit (BD Biosciences, San
Jose, CA). The 5 V-pr imer (ICP27-EcoRI-5 V; 5 V-
CGGAATTCGTCATGGCGACTGACATTGA-3V) was
complementary to nucleotides 1–17 (underlined) and had
at its 5Vend an EcoRI restriction enzyme site (bold). The 3V
primer (ICP27-XbaI-3V; 5V-GCTCTAGAGTACCTAAAA-
CAGGGAGTTGC-3V) was complementary to bases 1519–
1536 and contained an XbaI restriction site (bold) at its 5V
end. The 1.5 kb PCR amplification product was subcloned
into the EcoRI and XbaI sites of the pCI (Promega)-derived
vector pCIDAflII (Murphy et al., 2000). The subcloned
ICP27 ORF was verified by sequencing.
Fig. 7. Model for ICP27 and ICP8 interactions. ICP27 binds to RNAP II and this complex is recruited to progeny DNA by interactions with ICP8, which binds
to DNA, and ICP4, which complexes with cellular transcription factors (TF), thereby inducing the transcription of viral late mRNAs.
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plasmid, which expresses ICP27 as a maltose binding
protein (MBP) fusion, was constructed as follows. The
pMal-Dest vector, a gift from Brent Appleton and Jim
Hogle (Harvard Medical School, MA), was engineered
from pMAL-c2X (New England Biolabs) to contain
sequence encoding a PreScission protease site (Amersham
Biosciences, Piscataway, NJ), Gateway recombination sites
(Invitrogen), and EcoRI and XbaI restriction sites 3V to the
malE ORF. The ICP27 ORF from pCI-ICP27 was
subcloned into the engineered EcoRI and XbaI sites of
pMal-Dest vector, in frame with malE, to yield pMal-Dest-
ICP27. The pCI-MBP27 plasmid, which expresses the
MBP-ICP27 fusion protein in mammalian cells, was
generated by digestion of pMal-Dest-ICP27 with NdeI
and XbaI restriction enzymes. The NdeI and XbaI sites
were blunt ended by Klenow Polymerase (New England
Biolabs) and the DNA fragment was subcloned into the
SmaI site of the pCIDAflII vector. The orientation of the
inserted DNA fragment in pCIDAflII was determined via
analysis with restriction enzymes.
The pFastbac-ICP27 plasmid was created by subclon-
ing the ICP27 ORF from pCI-ICP27 into the EcoRI and
XbaI sites of pFastbac vector (Invitrogen). To construct
the pFastbacHT29 plasmid, the ICP8 ORF (UL29) was
subcloned in two steps from the CMV-8.3 plasmid (Taylor
et al., 2003) into pFastbacHT (Invitrogen), which contains
sequence encoding a hexahistidine affinity tag in the 5V
direction from the subcloned gene. First, an EcoRI and
SalI fragment, containing approximately 3350 nucleotides
of UL29, was subcloned from SV8.3 into pFastbacHT in
frame with the His-tag to generate pFastbacHTdsb.
Second, a small SalI fragment from SV8.3, containing
the 3Vend of UL29, was subcloned into pFastbacHTdsb to
construct the full-length UL29 construct (pFastbacHT29).
Baculoviruses for ICP27 and His-ICP8 were generatedfrom pFastbac-ICP27 and pFastbacHT29 in SF21 cells
with the Invitrogen Fastbac system.
HSV-1 KOS 1.1 (wt) strain (Hughes and Munyon, 1975)
was propagated on Vero cells. The previously described
ICP27 null deletion mutant virus d27-1 (Rice and Knipe,
1990) was grown on V827 cells.
Complementation assay
Vero cells were grown in T-25 flasks to 90%
confluence. Cells in duplicate flasks were transfected with
1.5 Ag of pCI-ICP27, pCI-MBP27, or pPs27pd1 plasmids
or pCIDAflII empty vector (mock control). Transfections
were performed with Lipofectamine 2000 reagent (Invi-
trogen). Cells were washed four times with cold phos-
phate-buffered saline (PBS) 24 h post-transfection and
subsequently infected with d27-1, the ICP27 null deletion
mutant virus, at an MOI of 5 PFU/cell at 37 8C. After 1 h,
the cells were washed four times with PBS to remove
unabsorbed virus, and 5 ml of DMEM + 1% FBCS was
added to the infected flask. Cells were harvested at 24 hpi
by freeze–thawing and sonicating three times for 30 s
on ice. Complementation of virus growth was measured
by plaque assay on the V827 ICP27-complementing cell
line.
Purification of His-ICP8 from TnHi5 insect cells
TnHi5 cells were grown in 1-l spinner flasks to a density
of 6  105 to 1  106 cells/ml before infection with the
recombinant ICP8 baculovirus. After incubation at 27 8C for
72–96 h, the infected cells were collected by centrifugation
at 500  g for 15 min. The cell pellets were washed twice
with PBS and suspended in lysis buffer (50 mM Tris–Cl, pH
7.7, 150 mM NaCl, 15% glycerol, 10 mM 2-mercaptoetha-
nol (h-ME), 5 mM EDTA, 0.2% NP40, 200 AM PMSF, and
M. Olesky et al. / Virology 331 (2005) 94–105102one Complete protease inhibitor cocktail tablet [Roche
Applied Science, Indianapolis, IN] per 20 ml). Cells were
incubated on ice for 30 min and disrupted by Dounce
homogenization. The cell lysate was clarified by centrifu-
gation (15,000  g; 20 min; 4 8C) and applied to a
Sepharose Q FF anion exchange column (Amersham
Biosciences) equilibrated with Buffer A (20 mM Tris–Cl,
pH 7.7, 150 mM NaCl, 15% glycerol, 10 mM h-ME). His-
ICP8 was eluted from the resin with a linear salt gradient
(0.15–0.5 M NaCl) in Buffer A and fractions containing
His-ICP8 were identified by UV absorbance and SDS-
PAGE, collected, and dialyzed against several changes of
Buffer B (50 mM Tris–Cl, pH 7.7, 150 mM NaCl, 5 mM
EDTA, 15% glycerol, and 10 mM h-ME). The dialyzed
sample was applied to an ssDNA agarose column (Amer-
sham Biosciences), equilibrated with Buffer B. His-ICP8
was eluted from the resin with Buffer B plus 1 M NaCl. The
fractions containing His-ICP8 were pooled, dialyzed against
Buffer C (20 mM Tris–Cl, pH 7.7, 500 mM NaCl, 20%
glycerol, and 4 mM h-ME), and applied to a nickel affinity
column (Amersham Biosciences) equilibrated with Buffer
C. His-ICP8 was eluted from the nickel affinity resin with a
linear gradient of imidazole (0.05–0.5 M) in Buffer C. His-
ICP8 fractions were pooled, dialyzed against Buffer D
(20 mM Tris, pH 7.7, 300 mM NaCl, 20% glycerol, 4 mM
TCEP (Amersham Biosciences), and stored at 80 8C in
aliquots. Protein concentration was determined by absor-
bance at 280 nm (Pace et al., 1995) and by Coomassie
staining relative to a bovine serum albumin standard curve
resolved by SDS-PAGE.
Purification of MBP-27 from BL21 E. coli cells
ICP27 was expressed in E. coli as a fusion protein at the
carboxy terminus of MBP. BL21-codon-optimized compe-
tent E. coli cells (Stratagene, La Jolla, CA) were transformed
with pMal-Dest-ICP27, and transformants were selected on
LB agar plates containing 100 Ag/ml carbenicillin (Sigma-
Aldrich, St. Louis, MO). Three-liter cultures of transformed
cells were grown in 2YT, 100 Ag/ml carbenicillin, and
11 mM glucose at 37 8C with shaking until the optical
density at 600 nm was approximately 0.6. IPTG was added
to a final concentration of 0.5 mM, and cells were incubated
at 16 8C overnight. The cells were harvested by low-speed
centrifugation for 20 min, washed once with cold MBP
buffer (20 mM Tris–HCl, 200 mM NaCl, 8 mM h-ME,
1 mM EDTA, 20% glycerol, 1 Complete protease inhibitor
cocktail tablet [Roche Applied Science] per 20 ml), and
lysed by sonication in MBP buffer containing DNase. All
subsequent steps were performed at 4 8C. Supernatants were
collected by centrifugation at 15,000 g and applied to 2 ml
column containing amylose resin (New England Biolabs)
that was equilibrated with MBP buffer. The resin was
washed with 5 column volumes of MBP buffer and MBP-27
was eluted with MBP buffer plus 10 mM maltose. Protein
concentration was determined via Coomassie stainingrelative to a bovine serum albumin standard curve resolved
by SDS-PAGE.
Immunoprecipitation assays
To prepare cellular lysates from mammalian cells for
immunoprecipitation assays, we mock infected or infected
HEp2 cells with HSV-1 KOS 1.1 (wt) or d27-1 viruses at an
MOI of 20 PFU/cell and harvested the infected cells at 8 hpi.
Cells were lysed on ice in 0.5–1 ml IP buffer (20 mM Tris-
acetate, pH 7.9, 40 mM NaCl, 1 mM EDTA, 120 mM
potassium-acetate, 1 mM DTT, 0.005–0.1% Nonidet P-40,
10% glycerol, and one Complete protease inhibitor cocktail
tablet [Roche Applied Science] per 20 ml) for 30 min.
Cellular lysates were clarified by centrifugation in an
Eppendorf microfuge for 10 min at 16,000  g. For insect
cell immunoprecipitation assays, SF21 cells were mock
infected or infected with recombinant ICP27 or ICP8
baculoviruses and harvested and lysed at 72 hpi as above.
To perform immunoprecipitation assays on purified pro-
teins, MBP-27 and His-ICP8 that were purified as described
were diluted separately or in combination in 0.5 ml IP buffer
and incubated overnight at 4 8C with gentle rotation.
All subsequent steps were performed at 4 8C. The cell
lysates and purified protein samples were precleared with an
equal mix of Protein A- and Protein G-coated beads (Roche
Applied Science) for 1 h to overnight. Five microliters of
H1119 mAb or 1–3 Al of 3-83 pAb was added to the
samples for 1 h with gentle rotation. Beads (25–50 Al) were
added and samples were incubated for an additional hour.
The beads were washed four times with IP buffer and boiled
in protein loading buffer prior to resolution of the
immunoprecipitates by SDS-PAGE and Western blotting.
Protein affinity pull-down assays
BL21 codon-optimized E. coli cells were transformed
with pMAL-Dest-ICP27 or pMAL-c2X plasmids, and
recombinant MBP-27 and MBP proteins were expressed
in E. coli as described above. Bacterial cells from 1-L
cultures were harvested via low speed centrifugation and
lysed in 20 ml MBP buffer by sonication. Approximately
40 Al of amylose resin was washed with MBP buffer and
subsequently blocked with MBP buffer + 2% BSA for
45 min at 4 8C. The blocked resin was washed with MBP
buffer and incubated with 500 Al MBP-27 or 50 Al MBP
supernatants for 2 h at 4 8C. Less MBP lysate was used
because MBP was expressed at levels approximately 10-
fold higher than MBP-27. MBP fusion-conjugated beads
were washed five times with MBP buffer, twice with IP
buffer (above), and incubated with 2.5 Ag of purified ICP8
in IP buffer overnight. Blocked, unconjugated resin was
used as a negative control for ICP8 nonspecific binding.
After four washes at 10 min each with IP buffer, SDS-PAGE
sample buffer was added and the beads were boiled for
10 min. Samples were analyzed via SDS-PAGE and
M. Olesky et al. / Virology 331 (2005) 94–105 103Western blotting, and His-ICP8 was detected with 3-83
pAb. Subsequently, the membrane was stripped and probed
with the anti-MBP mAb to detect MBP and MBP-27. RNase
(Ambion, Austin, TX; 25 U of RNase A/ml and 1000 U of
RNase T1/ml) and DNase (Sigma-Aldrich; 50 Ag/ml)
incubations were performed with cleared bacterial lysates
at 30 8C for 30 min prior to binding to amylose resin.
SDS-PAGE and Western blotting
Proteins were resolved on either 8–16% gradient or 10%
Tris-Glycine precast gels (Invitrogen) or diallytartardiamide
cross-linked 9.25% polyacrylamide gels. Gels were stained
with Coomassie Brilliant Blue R-250 (American Bioanalyti-
cal, Natick, MA) or transferred to polyvinyldene difluoride
(PVDF) membranes (Perkin-Elmer Life Sciences, Inc.,
Boston, MA) at 40 V overnight in transfer buffer (25 mM
Tris, 192 mM glycine, 15% methanol, pH 8.3). The
membranes were blocked in 5% milk in Tris-buffered saline
containing 0.05% Tween 20 (TBS-T) (pH 8.0) and probed
with the indicated primary antibodies. The anti-ICP27
(H1119), anti-ICP8 (3-83), and anti-MBP antibodies were
used at 1:300, 1:1000, and 1:10,000 dilutions, respectively.
Goat anti-rabbit and goat anti-mouse secondary antibodies
were diluted 1:10,000 in TBS-T. The proteins were
visualized with ECL Western blotting detection reagents
(Amersham Biosciences) according to the manufacturerVs
protocol. The membranes were stripped in 100 mM h-ME,
2% sodium dodecyl sulfate, 62.5 mM Tris–HCl, pH 6.7 at
56 8C for 1 h before reprobing.Acknowledgments
We thank Brent Appleton for excellent advice, technical
assistance, and providing the pMal-Dest plasmid. We also
thank Robin Colgrove and Errin Fontaine-Rodriguez for
helpful suggestions and for comments on this work and the
manuscript. Finally, we acknowledge Jim Hogle, Max
Nibert, and Donald Coen for use of equipment, Cheryl
Boehler for technical assistance, and Lisa Holik for editorial
assistance. This work was supported by NIH grants AI
20530 and AI 63106. M.O. was supported by training grant
AI 007245.References
Ackermann, M., Braun, D.K., Pereira, L., Roizman, B., 1984. Character-
ization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with
monoclonal antibodies. J. Virol. 52, 108–118.
Beard, P., Faber, S., Wilcox, K.W., Pizer, L.I., 1986. Herpes simplex virus
immediate early infected-cell polypeptide 4 binds to DNA and promotes
transcription. Proc. Natl. Acad. Sci. U.S.A. 83, 4016–4020.
Boehmer, P.E., Lehman, I.R., 1993. Herpes simplex virus type 1 ICP8:
helix-destabilizing properties. J. Virol. 67, 711–715.
Bortner, C., Hernandez, T.R., Lehman, I.R., Griffith, J., 1993. Herpes
simplex virus 1 single-strand DNA-binding protein (ICP8) willpromote homologous pairing and strand transfer. J. Mol. Biol. 231,
241–250.
Brown, C.R., Nakamura, M.S., Mosca, J.D., Hayward, G.S., Straus, S.E.,
Perera, L.P., 1995. Herpes simplex virus trans-regulatory protein ICP27
stabilizes and binds to 3Vends of labile mRNA. J. Virol. 69, 7187–7195.
Bryant, H.E., Matthews, D.A., Wadd, S., Scott, J.E., Kean, J., Graham, S.,
Russell, W.C., Clements, J.B., 2000. Interaction between herpes
simplex virus type 1 IE63 protein and cellular protein p32. J. Virol.
74, 11322–11328.
Bryant, H.E., Wadd, S.E., Lamond, A.I., Silverstein, S.J., Clements, J.B.,
2001. Herpes simplex virus IE63 (ICP27) protein interacts with
spliceosome-associated protein 145 and inhibits splicing prior to the
first catalytic step. J. Virol. 75, 4376–4385.
Carrozza, M., DeLuca, N., 1996. Interactions of the viral activator
protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 16,
3085–3093.
Carrozza, M.J., DeLuca, N., 1998. The high mobility group protein 1 is
a coactivator of herpes simplex virus ICP4 in vitro. J. Virol. 72,
6752–6757.
Challberg, M.D., 1986. A method for identifying the viral genes required
for herpesvirus DNA replication. Proc. Natl. Acad. Sci. U.S.A. 83,
9094–9098.
Chen, Y.M., Knipe, D.M., 1996. A dominant mutant form of the herpes
simplex virus ICP8 protein decreases viral late gene transcription.
Virology 221, 281–290.
Chen, I.H., Sciabica, K.S., Sandri-Goldin, R.M., 2002. ICP27 interacts
with the RNA export factor Aly/REF to direct herpes simplex virus
type 1 intronless mRNAs to the TAP export pathway. J. Virol. 76,
12877–12889.
Conley, A.J., Knipe, D.M., Jones, P.C., Roizman, B., 1981. Molecular
genetics of herpes simplex virus. VII. Characterization of a temperature-
sensitive mutant produced by in vitro mutagenesis and defective in
DNA synthesis and accumulation of gamma polypeptides. J. Virol. 37,
191–206.
Da Costa, X.J., Kramer, M.F., Zhu, J., Brockman, M.A., Knipe, D.M.,
2000. Construction, phenotypic analysis, and immunogenicity of a
UL5/UL29 double deletion mutant of herpes simplex virus 2. J. Virol.
74, 7963–7971.
de Bruyn Kops, A., Uprichard, S.L., Chen, M., Knipe, D.M., 1998.
Comparison of the intranuclear distributions of herpes simplex virus
proteins involved in different viral functions. Virology 252, 162–178.
DeLuca, N.A., Schaffer, P.A., 1985. Activation of immediate-early,
early, and late promoters by temperature-sensitive and wild-type
forms of herpes simplex virus type 1 protein ICP4. Mol. Cell. Biol.
5, 1208–1997.
DeLuca, N.A., McCarthy, A.M., Schaffer, P.A., 1985. Isolation and
characterization of deletion mutants of herpes simplex virus type 1 in
the gene encoding immediate-early regulatory protein ICP4. J. Virol.
56, 558–570.
Dudas, K.C., Ruyechan, W.T., 1998. Identification of a region of the herpes
simplex virus single-stranded DNA-binding protein involved in
cooperative binding. J. Virol. 72, 257–265.
Dutch, R.E., Lehman, I.R., 1993. Renaturation of complementary DNA
strands by herpes simplex virus type 1 ICP8. J. Virol. 67, 6945–6949.
Ellison, K.S., Rice, S.A., Verity, R., Smiley, J.R., 2000. Processing of
alpha-globin and ICP0 nRNA in cells infected with herpes simplex
virus type 1 ICP27 mutants. J. Virol. 74, 7307–7319.
Faber, S.W., Wilcox, K.W., 1986. Association of the herpes simplex virus
regulatory protein ICP4 with specific nucleotide sequences in DNA.
Nucleic Acids Res. 14, 6067–6083.
Faber, S.W., Wilcox, K.W., 1988. Association of herpes simplex virus
regulatory protein ICP4 with sequences spanning the ICP4 gene
transcription initiation site. Nucleic Acids Res. 16 (2), 555–570.
Gao, M., Knipe, D.M., 1989. Genetic evidence for multiple nuclear
functions of the herpes simplex virus ICP8 DNA-binding protein.
J. Virol. 63, 5258–5267.
Gao, M., Knipe, D.M., 1991. Potential role for herpes simplex virus ICP8
M. Olesky et al. / Virology 331 (2005) 94–105104DNA replication protein in stimulation of late gene expression. J. Virol.
65, 2666–2675.
Godowski, P.J., Knipe, D.M., 1983. Mutations in the major DNA-binding
protein gene of herpes simplex virus type 1 result in increased levels of
viral gene expression. J. Virol. 47, 478–486.
Godowski, P.J., Knipe, D.M., 1985. Identification of a herpes simplex virus
function that represses late gene expression from parental viral
genomes. J. Virol. 55, 357–365.
Godowski, P.J., Knipe, D.M., 1986. Transcriptional control of herpesvirus
gene expression: gene functions required for positive and negative
regulation. Proc. Natl. Acad. Sci. U.S.A. 83, 256–260.
Grondin, B., DeLuca, N., 2000. Herpes simplex virus type 1 ICP4 promotes
transcription preinitiation complex formation by enhancing the binding
of TFIID to DNA. J. Virol. 74, 11504–11510.
Hann, L.E., Cook, W.J., Uprichard, S.L., Knipe, D.M., Coen, D.M., 1998.
The role of herpes simplex virus ICP27 in the regulation of UL24 gene
expression by differential polyadenylation. J. Virol. 72, 7709–7714.
Hardwicke, M.A., Sandri-Goldin, R.M., 1994. The herpes simplex virus
regulatory protein ICP27 contributes to the decrease in cellular mRNA
levels during infection. J. Virol. 68, 4797–4810.
Hardy, W.R., Sandri-Goldin, R.M., 1994. Herpes simplex virus inhibits host
cell splicing, and regulatory protein ICP27 is required for this effect.
J. Virol. 68, 7790–7799.
Hughes Jr., R.G., Munyon, W.H., 1975. Temperature-sensitive mutants of
herpes simplex virus type 1 defective in lysis but not in transformation.
J. Virol. 16, 275–283.
Ingram, A., Phelan, A., Dunlop, J., Clements, J.B., 1996. Immediate early
protein IE63 of herpes simplex virus type 1 binds RNA directly. J. Gen.
Virol. 77, 1847–1851.
Jean, S., LeVan, K.M., Song, B., Levine, M., Knipe, D.M., 2001. Herpes
simplex virus 1 ICP27 is required for transcription of two viral late
(gamma2) genes in infected cells. Virology 283, 273–284.
Jenkins, H.L., Spencer, C.A., 2001. RNA polymerase II holoenzyme
modifications accompany transcription reprogramming in herpes
simplex virus type 1-infected cells. J. Virol. 75, 9872–9884.
King, L.A., Possee, R.D., 1992. Baculovirus Expression System: A
Laboratory Guide. Chapman & Hall, London.
Knipe, D.M., Senechek, D., Rice, S.A., Smith, J.L., 1987. Stages in the
nuclear association of the herpes simplex virus transcriptional activator
protein ICP4. J. Virol. 61, 276–284.
Kristie, T.M., Roizman, B., 1986a. Alpha 4, the major regulatory protein of
herpes simplex virus type 1, is stably and specifically associated with
promoter-regulatory domains of alpha genes and of selected other viral
genes. Proc. Natl. Acad. Sci. U.S.A. 83, 3218–3222.
Kristie, T.M., Roizman, B., 1986b. DNA-binding site of major regulatory
protein alpha 4 specifically associated with promoter-regulatory
domains of alpha genes of herpes simplex virus type 1. Proc. Natl.
Acad. Sci. U.S.A. 83 (13), 4700–4704.
Kuddus, R., Gu, B., DeLuca, N.A., 1995. Relationship between TATA-
binding protein and herpes simplex virus type 1 ICP4 DNA-binding
sites in complex formation and repression of transcription. J. Virol. 69,
5568–5575.
Lee, C.K., Knipe, D.M., 1985. An immunoassay for the study of DNA-
binding activities of herpes simplex virus protein ICP8. J. Virol. 54,
731–738.
Lehman, I.R., Boehmer, P.E., 1999. Replication of herpes simplex virus
DNA. J. Biol. Chem. 274, 28059–28062.
Lindberg, A., Kreivi, J.P., 2002. Splicing inhibition at the level of
spliceosome assembly in the presence of herpes simplex virus protein
ICP27. Virology 294, 189–198.
Luckow,V.A., 1991. In: Prokop,A.,Bajpai,R.K.,Ho,C. (Eds.),Recombinant
DNATechnology and Applications. McGraw-Hill, New York, NY.
Mapelli, M., Tucker, P.A., 1999. Crystallization and preliminary X-ray
crystallographic studies on the herpes simplex virus 1 single-stranded
DNA binding protein. J. Struct. Biol. 128, 219–222.
Mapelli, M., Muhleisen, M., Persico, G., van Der Zandt, H., Tucker, P.A.,
2000. The 60-residue C-terminal region of the single-stranded DNAbinding protein of herpes simplex virus type 1 is required for
cooperative DNA binding. J. Virol. 74, 8812–8822.
McCarthy, A.M., McMahan, L., Schaffer, P.A., 1989. Herpes simplex virus
type 1 ICP27 deletion mutants exhibit altered patterns of transcription
and are DNA deficient. J. Virol. 63, 18–27.
McGregor, F., Phelan, A., Dunlop, J., Clements, J.B., 1996. Regulation
of herpes simplex virus poly(A) site usage and the action of
immediate-early protein IE63 in the early-late switch. J. Virol. 70,
1931–1940.
McLauchlan, J., Phelan, A., Loney, C., Sandri-Goldin, R.M., Clements,
J.B., 1992. Herpes simplex virus IE63 acts at the posttranscrip-
tional level to stimulate viral mRNA 3V processing. J. Virol. 66,
6939–6945.
Mears, W.E., Rice, S.A., 1996. The RGG box motif of the herpes simplex
virus ICP27 protein mediates an RNA-binding activity and determines
in vivo methylation. J. Virol. 70, 7445–7453.
Michael, N., Spector, D., Mavromara-Nazos, P., Kristie, T.M., Roiz-
man, B., 1988. The DNA-binding properties of the major
regulatory protein alpha 4 of herpes simplex viruses. Science 239,
1531–1534.
Mullen, M.A., Gerstberger, S., Ciufo, D.M., Mosca, J.D., Hayward, G.S.,
1995. Evaluation of colocalization interactions between the IE110,
IE175, and IE63 transactivator proteins of herpes simplex virus within
subcellular punctate structures. J. Virol. 69, 476–491.
Murphy, C.G., Lucas, W.T., Means, R., Czajak, S., Hale, C.L., Lifson, J.D.,
Kauer, A., Johnson, R.P., Knipe, D.M., Desrosiers, R.C., 2000. Vaccine
protection against simian immunodeficiency virus by recombinant
strains of herpes simplex virus. J. Virol. 74, 7745–7753.
O’Hare, P., Hayward, G.S., 1985. Three trans-acting regulatory proteins of
herpes simplex virus modulate immediate-early gene expression in a
pathway involving positive and negative feedback regulation. J. Virol.
56 (3), 723–733.
Pace, C.N., Vajdos, F., Fee, L., Grimsley, G., Gray, T., 1995. How to
measure and predict the molar absorption coefficient of a protein.
Protein Sci. 4, 2411–2423.
Panagiotidis, C.A., Lium, E.K., Silverstein, S.J., 1997. Physical and
functional interactions between herpes simplex virus immediate-early
proteins ICP4 and ICP27. J. Virol. 71, 1547–1557.
Pearson, A., Knipe, D.M., Coen, D.M., 2004. ICP27 selectively regulates
the cytoplasmic localization of a subset of viral transcripts in herpes
simplex virus type 1-infected cells. J. Virol. 78, 23–32.
Phelan, A., Dunlop, J., Clements, J.B., 1996. Herpes simplex virus type 1
protein IE63 affects the nuclear export of virus intron-containing
transcripts. J. Virol. 70, 5255–5265.
Planson, A.G., Guijarro, J.I., Goldberg, M.E., Chaffotte, A.F., 2003.
Assistance of maltose binding protein to the in vivo folding of the
disulfide-rich C-terminal fragment from Plasmodium falciparum mer-
ozoite surface protein 1 expressed in Escherichia coli. Biochemistry 42,
13202–13211.
Preston, C.M., 1979. Control of herpes simplex virus type 1 mRNA
synthesis in cells infected with wild-type virus or the temperature-
sensitive mutant tsK. J. Virol. 29, 275–284.
Purifoy, D.J., Powell, K.L., 1976. DNA-binding proteins induced by herpes
simplex virus type 2 in HEp-2 cells. J. Virol. 19 (2), 717–731.
Rice, S.A., Knipe, D.M., 1990. Genetic evidence for two distinct
transactivation functions of the herpes simplex virus alpha protein
ICP27. J. Virol. 64, 1704–1715.
Rice, S.A., Su, L.S., Knipe, D.M., 1989. Herpes simplex virus alpha
protein ICP27 possesses separable positive and negative regulatory
activities. J. Virol. 63, 3399–3407.
Roizman, B., Knipe, D.M., 2001. Herpes simplex viruses and their
replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields
Virology, 4th ed. Lippincott, Williams and Wilkins, Philadelphia,
PA, pp. 2399–2460.
Ruyechan,W.T., 1983. Themajor herpes simplex virus DNA-binding protein
holds single-stranded DNA in an extended configuration. J. Virol. 46,
661–666.
M. Olesky et al. / Virology 331 (2005) 94–105 105Ruyechan, W.T., 1988. N-ethylmaleimide inhibition of the DNA-binding
activity of the herpes simplex virus type 1 major DNA-binding protein.
J. Virol. 62, 810–817.
Sacks, W.R., Greene, C.C., Aschman, D.P., Schaffer, P.A., 1985. Herpes
simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol.
55, 796–805.
Samaniego, L.A., Webb, A.L., DeLuca, N.A., 1995. Functional interactions
between herpes simplex virus immediate early proteins during infection:
gene expression as a consequence of ICP27 and different domains of
ICP4. J. Virol. 69, 5705–5715.
Sandri-Goldin, R.M., 1998. ICP27 mediates HSV RNA export by shuttling
through a leucine-rich nuclear export signal and binding viral intronless
RNAs through an RGG motif. Genes Dev. 12, 868–879.
Sandri-Goldin, R.M., 2004. Viral regulation of mRNA export. J. Virol. 78,
4389–4396.
Sciabica, K.S., Dai, Q.J., Sandri-Goldin, R.M., 2003. ICP27 interacts with
SRPK1 to mediate HSV splicing inhibition by altering SR protein
phosphorylation. EMBO J. 22, 1608–1619.
Smith, C.A., Bates, P., Rivera-Gonzalez, R., Gu, B., DeLuca, N.A., 1993.
ICP4, the major transcriptional regulatory protein of herpes simplex
virus type 1, forms a tripartite complex with TATA-binding protein and
TFIIB. J. Virol. 67, 4676–4687.
Sokolowski, M., Scott, J.E., Heaney, R.P., Patel, A.H., Clements, J.B.,
2003. Identification of herpes simplex virus RNAs that interact
specifically with regulatory protein ICP27 in vivo. J. Biol. Chem. 278
(35), 33540–33549.
Song, B., Yeh, K.C., Liu, J.J., Knipe, D.M., 2001. Herpes simplex virus
gene products required for viral infection of expression of G1-phase
functions. Virology 290, 320–328.
Spatz, M., Ali, S.A., Auer, M., Graf, C., Eibl, M.M., Steinkasserer, A.,1999. Circular dichroism analysis of insect cell expressed herpes
simplex virus type I single-stranded DNA-binding protein ICP8. Protein
Expr. Purif. 16, 40–46.
Taylor, T.J., Knipe, D.M., 2004. Proteomics of herpes simplex virus
replication compartments: association of cellular DNA replication,
repair, recombination, and chromatin remodeling proteins with ICP8.
J. Virol. 78, 5856–5866.
Taylor, T.J., McNamee, E.E., Day, C., Knipe, D.M., 2003. Herpes simplex
virus replication compartments can form by coalescence of smaller
compartments. Virology 309, 232–247.
Uprichard, S.L., Knipe, D.M., 1996. Herpes simplex virus ICP27 mutant
viruses exhibit reduced expression of specific DNA replication genes.
J. Virol. 70, 1969–1980.
Wadd, S., Bryant, H., Filhol, O., Scott, J.E., Hsieh, T.Y., Everett, R.D.,
Clements, J.B., 1999. The multifunctional herpes simplex virus IE63
protein interacts with heterogeneous ribonucleoprotein K and with
casein kinase 2. J. Biol. Chem. 274, 28991–28998.
Wilcox, K.W., Kohn, A., Sklyanskaya, E., Roizman, B., 1980. Herpes
simplex virus phosphoproteins. I. Phosphate cycles on and off some
viral polypeptides and can alter their affinity for DNA. J. Virol. 33,
167–182.
Xia, K., DeLuca, N.A., Knipe, D.M., 1996. Analysis of phosphorylation
sites of the herpes simplex virus 1 infected cell protein 4 (ICP4).
J. Virol. 70, 1061–1071.
Zhi, Y., Sandri-Goldin, R.M., 1999. Analysis of the phosphorylation sites of
herpes simplex virus type 1 regulatory protein ICP27. J. Virol. 73,
3246–3257.
Zhou, C., Knipe, D.M., 2002. Association of herpes simplex virus type 1
ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme.
J. Virol. 76, 5893–5904.
